WATERTOWN, Mass., Jan. 06, 2026 (GLOBE NEWSWIRE) -- Acrivon Therapeutics, Inc. (ACRV), a clinical stage biotechnology company discovering and developing precision medicines utilizing its proprietary ...
Acrivon is a clinical stage biopharmaceutical company discovering and developing precision medicines utilizing its proprietary Generative Phosphoproteomics AP3 platform. The platform allows the ...
While DevOps drives innovation and simplifies collaboration, it also comes with its own set of risks and vulnerabilities. Developers rely on Git-based platforms like GitHub, Azure DevOps, Bitbucket, ...
A monthly overview of things you need to know as an architect or aspiring architect. Unlock the full InfoQ experience by logging in! Stay updated with your favorite authors and topics, engage with ...
SAN FRANCISCO and SUZHOU, China, Nov. 4, 2025 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures, and ...
Preclinical data highlight MTHFD2 as a promising metabolic target in autoimmune disease, providing strong validation for the advancement of SIT-047, Sitryx’s MTHFD2 inhibitor program, into clinical ...
WALTHAM, Mass., Oct. 24, 2025 (GLOBE NEWSWIRE) -- Spyre Therapeutics, Inc. (NASDAQ: SYRE), a clinical-stage biotechnology company pioneering long-acting antibodies and antibody combinations to ...
East Hanover, October 25, 2025 – Novartis announced today plans to present data from 27 company- or investigator-sponsored abstracts across its Immunology portfolio and pipeline at the 2025 American ...
Acrivon Therapeutics focuses on developing targeted cancer therapies using its proprietary AP3 platform, which is a proteomics-based technology. The AP3 platform analyzes proteins inside tumor cells ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results